Eurosurveillance



The EpiNorth project area

Welcome to the EpiNorth home-page!

The EpiNorth project aims to improve communicable disease surveillance, control and communication in the Nordic and Baltic countries and north-west regions of Russia.

On this site you can find information about epidemiological surveillance and outbreaks in various countries (EpiWatch), news about the events within the networks in cooperating countries (EpiNews), the online version of the bilingual epidemiological journal (EpiNorth Journal), data on notifiable infectious diseases from our region (EpiNorthData), national vaccination programmes in cooperating countries (EpiVax), educational and training material from our training courses (EpiTrain), links within our networks (EpiLinks) and information on  cooperation projects with Russia summarized in reports published by Norwegian Institute of Public Health (NIPH projects). For the years 2007 - 2009, EpiNorth is partly funded by the European Centre for Disease Prevention and Control (ECDC). EpiNorths Secretariat is at the Norwegian Institute of Public Health.

We hope that information on the website will be useful for you . Please provide your feedback to us at epinorth@fhi.no.

                                                                                                 

EpiWatch

New influenza A (H1N1): Assessment of the situation as of 23 June

[23.06.09]

The EpiNorth secretariat publishes this updated risk assessment at least once a month:

Conclusion
The most likely scenario is an introduction of the virus to most countries over the next few weeks and a large epidemic in the southern hemisphere over the next months while the northern hemisphere will experience a relatively calm period this summer (possibly with some outbreaks in closed settings like health care institutions, cruise ships and schools), followed by a large outbreak in the autumn or winter. However, it is not much less likely that there is a first wave in the north already this summer, like in the USA now. We do not know what percentage of the population will be infected and what percentage of the infected that will fall ill. The clinical presentation is largely mild, but some complicated cases and deaths do occur, even in previously health young people. We do not know whether the virus will acquire new genes that change its antiviral resistance or virulence or that may make it necessary to change the virus used for vaccine production.


Read more...
 

 

EpiNews

News: publication ahead of print

[25.06.09]
The article "Prioritisation of infectious diseases in public health - call for comments" by Krause G et al. with its translation into Russian is now available online. The translation is made by the EpiNorth project. The article will be printed in one of the coming issues of the EpiNorth Journal. Readers can find a complete electronic version of the article here.